Qube Research & Technologies LTD Clene Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.26 - $0.55 $0 - $1	2 New	2 $0
Q3 2022 Nov 14, 2022	BUY	$0.33 - $73.0 $6,847 - $1.51 Million	20,749 New	20,749 $58,000
Q2 2021 Aug 13, 2021	SELL	$6.98 - $13.33 $318,664 - $608,567	-45,654 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.39 - $16.3 $291,729 - $744,160	45,654 New	45,654 $583,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.